The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapyJiawen Qian, Yiwei Chu, Chen Wang et al.|Journal of Neuroinflammation|2018Cited by 264
TLR2 Promotes Glioma Immune Evasion by Downregulating MHC Class II Molecules in MicrogliaJiawen Qian, Yiwei Chu, Jiyang Wang et al.|Cancer Immunology Research|2018Cited by 137
Acetylcholine ameliorates colitis by promoting IL-10 secretion of monocytic myeloid-derived suppressor cells through the nAChR/ERK pathwayWanwei Zheng, Jie Liu, Huan Song et al.|Proceedings of the National Academy of Sciences|2021Cited by 103
Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation AntigenMarijke Timmers, Sébastien Anguille, Gils Roex et al.|Frontiers in Immunology|2019Cited by 90
MiR‐15a/16 deficiency enhances anti‐tumor immunity of glioma‐infiltrating CD8+ T cells through targeting mTORJiao Yang, Yiwei Chu, Ronghua Liu et al.|International Journal of Cancer|2017Cited by 82